Anti-Mouse CD28 - DyLight® 594

Leinco Technologies
Product Code: LEI-C1703
Product Group: Primary Antibodies
CodeSizePrice
LEI-C1703-50ug50 ug£159.00
Quantity:
LEI-C1703-100ug100 ug£211.00
Quantity:
LEI-C1703-200ug200 ug£291.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Hamster
Antibody Clonality: Monoclonal
Antibody Clone: 37.51
Regulatory Status: RUO
Target Species: Mouse
Application: Flow Cytometry
Shipping:
2-8°C
Storage:
This DyLight® 594 conjugate is stable when stored at 2-8°C. Do not freeze.

Further Information

Antigen Distribution:
CD28 is expressed on thymocytes, CD4+, CD8+ peripheral T cells, NK cells.
Concentration:
0.2 mg/ml
Conjugate/Tag/Label:
DyLight® 594
Format:
This DyLight® 594 conjugate is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4, 1% BSA and 0.09% sodium azide as a preservative.
Formulation:
This DyLight® 594 conjugate is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4, 1% BSA and 0.09% sodium azide as a preservative.
Long Description:
CD28 is a 44 kD glycoprotein and a member of the Ig superfamily. In its capacity as a costimulatory receptor, CD28 produces co-stimulatory signals necessary for T cell activation and survival. CD28 is the only B7 receptor constitutively expressed on naive T cells. Without having this CD28/B7 interaction, T cells will fail to respond to their specific antigen when coming in contact with an MHC/antigen complex and thus, are said to be anergic.
NCBI Gene:
12487
Target:
CD28

References

1. Gross, J. A. et al. (1992) J. Immunol. 149:380

Related Products

Product NameProduct CodeSupplier 
Anti-Mouse CD28 - Purified in vivo PLATINUM™ Functional GradeLEI-C1658Leinco Technologies Summary Details
Anti-Mouse CD28 - DyLight® 550LEI-C1702Leinco Technologies Summary Details
Anti-Mouse CD28 - DyLight® 650LEI-C1705Leinco Technologies Summary Details
Anti-Mouse CD28 - PerCPLEI-C1709Leinco Technologies Summary Details
Anti-Human CD28 - Purified in vivo GOLD™ Functional GradeLEI-C2820Leinco Technologies Summary Details